Trial
NCT01500798
A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Chronic Kidney Disease
Intervention
20 mg bardoxolone methyl
Why stopped
IDMC recommendation for safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-27